reference/12907182

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12907182

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2075-4418
issueIdentifier	9
pageRange	732-
publicationName	Diagnostics (Basel, Switzerland)
startingPage	732
bibliographicCitation	Wetz C, Rogasch J, Genseke P, Schatka I, Furth C, Kreissl M, Jann H, Venerito M, Amthauer H. Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment? Diagnostics (Basel). 2020 Sep 22;10(9). PMID: 32971877; PMCID: PMC7554807.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4414-0657 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e134cc5f3a7be917a14a42cb5407de09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_292f37a7c5591aa769eab2bcb998f5fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7302-7886 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4095-336X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ec7d4c3550a20c534da07ee33cab44e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5905-6015 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa4d4f53d34003ccc1a57dadb52551ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0817-6532 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c60ca6e473c1d9a5316859313f148bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce166a56463e947c7ba9c3e878654e5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b5a0e8f24cc202c96754c33d87fc49b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bff345ef6dfe1af11ecebea171ecb7a2
date	2020-09-22^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7554807 https://pubmed.ncbi.nlm.nih.gov/32971877 https://doi.org/10.3390/diagnostics10090732
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43835 https://portal.issn.org/resource/ISSN/2075-4418
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129628179 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86289069 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8352 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6400441 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9833807 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44420813 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID464 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID383414 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49800006 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID155903738 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10250 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44311916 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448601 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57181882 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081912 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122173801 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90488715 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Showing number of triples: 1 to 51 of 51.